DST funded start-up s ELISA test to better estimate COVID 19 antibody concentration ANI | Updated: May 22, 2021 11:00 IST
The ministry in an official statement said that it was a Bangalore-based start-up that developed a novel, point-of-care Electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID 19 in clinical samples. The handheld device provides the results within five minutes. PathShodh Healthcare, the start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has made a very significant breakthrough to develop the first of its kind, semi-quantitative Electrochemical ELISA test for COVID-19 IgM and IgG antibodies. While Qualitative analysis detects constituent elements in the sample, the semiquantitative analysis gives an approximate estimation of their concentrations. PathShodh has received the license to manufacture for sale from t
New Delhi [India], May 22 (ANI): A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test to estimate accurate antibody concentration of COVID-19 in clinical samples, informed the Union Science and Technology Ministry on Saturday.
Electrochemical ELISA: Novel test for total Covid antibody concentration prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
PathShodh received the license to manufacture the test for sale from the Central Drugs Standard Control Organisation, after careful examination and validation from the Translational Health Science and Technology Institute, as per the requirements of the Indian Council of Medical Research (ICMR).